首页> 外文期刊>Journal of Biomolecular Structure and Dynamics >Combinatorial peptide library screening for discovery of diverse α-glucosidase inhibitors using molecular dynamics simulations and binary QSAR models
【24h】

Combinatorial peptide library screening for discovery of diverse α-glucosidase inhibitors using molecular dynamics simulations and binary QSAR models

机译:使用分子动力学模拟和二元QSAR模型的多种α-葡糖苷酶抑制剂发现的组合肽库筛选

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Human ?glucosidase is an enzyme involved in the catalytic cleavage of the glucoside bond and involved in numerous functionalities of the organism, as well as in the insurgence of diabetes mellitus 2 and obesity. Thus, developing chemicals that inhibit this enzyme is a promising approach for the treatment of several pathologies. Small peptides such as di- and tri-peptides may be in natural organism as well as in the GI tract in high concentration, coming from the digestive process of meat, wheat and milk proteins. In this work, we reported the first tentative hierarchical structure-based virtual screening of peptides for human ?glucosidase. The goal of this work is to discover novel and diverse lead compounds that my act as inhibitors of ?glucosidase such as small peptides by performing a computer aided virtual screening and to find novel scaffolds for further development. Thus, in order to select novel candidates with original structure we performed molecular dynamics (MD) simulations among the 12 top-ranked peptides taking as comparison the MD simulations performed on crystallographic inhibitor acarbose. The compounds with the lower RMSD variability during the MD, were reserved for in vitro biological assay. The selected 4 promising structures were prepared on solid phase peptide synthesis and used for the inhibitory assay, among them compound 2 showed good inhibitory activity, which validated our method as an original strategy to discover novel peptide inhibitors. Moreover, pharmacokinetic profile predictions of these 4 peptides were also carried out with binary QSAR models using MetaCore/MetaDrug applications. ?2018, ?2018 Informa UK Limited, trading as Taylor & Francis Group.
机译:人类?葡萄糖苷酶是参与葡萄糖苷键的催化切割并参与生物的许多功能,以及糖尿病2和肥胖症的叛乱。因此,开发抑制该酶的化学品是治疗几种病理的有希望的方法。小肽如二肽和三肽可以是天然生物,以及高浓度的GI沟中,来自肉类,小麦和牛奶蛋白的消化过程。在这项工作中,我们报道了第一个基于初步的分层结构的虚拟筛选人类的葡萄糖蛋白酶的肽。这项工作的目标是探索新的和多样化的铅化合物,即我作为葡萄糖蛋白酶的抑制剂,例如小肽,通过执行计算机辅助虚拟筛选并寻找新的支架进行进一步发展。因此,为了选择具有原始结构的新候选者,我们在12个排名肽中进行的分子动力学(MD)模拟,以表现为对晶体抑制螨的晶体抑制剂进行的MD模拟。在MD期间的RMSD变异性降低的化合物被保留用于体外生物测定。所选择的4个有希望的结构在固相肽合成上制备并用于抑制性测定,其中化合物2显示出良好的抑制活性,该抑制活性验证了我们作为发现新型肽抑制剂的原始策略的方法。此外,还使用Metacore / Metadrug应用,使用二元QSAR模型进行这4个肽的药代动力学曲线预测。 ?2018年,?2018年Informa Informa Limited,贸易为泰勒和弗朗西斯集团。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号